ANG Lifesciences India Ltd

ANG Lifesciences Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

ANG Lifesciences India Ltd

₹ 52.5 3.18%
24 Jul - close price
anglifesciences.com BSE: 540694
About

Incorporated in 2006, ANG Lifesciences India Ltd manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials[1]

Key Points

Business Overview:[1][2]
Company manufactures and sells products like injections, tablets, capsules, syrups, ointments of different varieties. It deals in 4 market segments: institutional segment, third party manufacturing, direct marketing and export market. Apart from this, company is also providing printing & packing solutions especially in mono cartons, paper printing, corrugation, aluminiumfoils (blister foils)

Website BSE
  • Market Cap ₹ 68.6 Cr.
  • Current Price ₹ 52.5
  • High / Low ₹ 86.1 / 44.5
  • Stock P/E
  • Book Value ₹ 59.0
  • Dividend Yield 0.00 %
  • ROCE 1.59 %
  • ROE -8.51 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.89 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 1.61% over past five years.
  • Promoters have pledged 44.9% of their holding.
  • Company has high debtors of 192 days.
  • Working capital days have increased from 131 days to 213 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
35.93 118.00 87.68 47.12 95.87 71.56 58.39 45.17 31.88 50.61 29.58 17.10 34.08
32.03 88.87 68.55 42.41 83.74 60.28 49.15 43.03 43.48 44.94 28.26 18.82 30.23
Operating Profit 3.90 29.13 19.13 4.71 12.13 11.28 9.24 2.14 -11.60 5.67 1.32 -1.72 3.85
OPM % 10.85% 24.69% 21.82% 10.00% 12.65% 15.76% 15.82% 4.74% -36.39% 11.20% 4.46% -10.06% 11.30%
0.58 0.08 0.11 0.13 0.62 0.12 0.20 0.32 9.20 0.34 0.33 -0.09 -1.49
Interest 1.06 1.34 1.34 1.69 3.51 3.17 3.20 2.84 1.11 1.94 1.96 1.99 3.44
Depreciation 1.32 0.36 1.03 1.35 2.37 1.88 1.90 1.92 2.82 1.94 1.97 2.02 1.83
Profit before tax 2.10 27.51 16.87 1.80 6.87 6.35 4.34 -2.30 -6.33 2.13 -2.28 -5.82 -2.91
Tax % 24.29% 25.26% 24.96% 32.78% 23.14% 47.24% 39.63% -30.43% -20.54% 25.35% -10.09% -20.96% 23.71%
1.60 20.55 12.66 1.22 5.28 3.34 2.62 -1.60 -5.03 1.60 -2.05 -4.59 -3.60
EPS in Rs 1.23 15.81 9.74 0.94 4.06 2.57 2.02 -1.23 -3.85 1.23 -1.57 -3.52 -2.76
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
16 34 37 55 67 75 121 126 154 349 207 131
14 30 34 50 60 68 110 114 139 283 195 122
Operating Profit 3 5 3 5 6 7 12 12 15 66 12 9
OPM % 16% 14% 8% 9% 10% 10% 10% 10% 10% 19% 6% 7%
0 0 0 0 0 1 0 0 1 1 10 -1
Interest 2 2 2 2 2 2 3 3 4 8 11 9
Depreciation 1 3 1 1 1 1 1 1 2 5 9 8
Profit before tax 0 0 1 2 4 5 8 8 10 53 2 -9
Tax % 140% 56% 32% 25% 26% 25% 30% 28% 26% 25% 132% -2%
-0 0 0 2 3 4 6 6 7 40 -1 -9
EPS in Rs -0.07 0.21 0.43 1.79 3.07 2.86 4.35 4.69 5.58 30.55 -0.51 -6.62
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 3% 0% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 2%
3 Years: -5%
TTM: -36%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -1674%
Stock Price CAGR
10 Years: %
5 Years: 30%
3 Years: -20%
1 Year: -20%
Return on Equity
10 Years: 17%
5 Years: 15%
3 Years: 14%
Last Year: -9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 4 4 4 4 4 5 5 5 5 10 13 13
Reserves -1 -1 -1 1 4 18 24 29 36 73 72 64
13 11 10 12 14 17 22 21 42 61 56 59
6 11 13 19 25 28 30 39 58 124 111 81
Total Liabilities 21 25 26 35 47 68 81 94 142 269 252 217
11 9 9 9 9 9 21 21 22 82 79 53
CWIP 0 0 0 0 0 12 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 4 4 4
10 16 17 26 38 47 60 73 120 183 170 161
Total Assets 21 25 26 35 47 68 81 94 142 269 252 217

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-8 4 3 2 3 1 7 5 -11 27 26 -13
-2 -2 -2 -3 -3 -13 -1 -2 -8 -42 -9 20
10 -1 -1 2 -0 13 -4 -4 19 15 -17 -7
Net Cash Flow 0 0 -0 1 -0 1 3 -1 -0 0 -0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 96 80 62 109 139 156 126 133 139 104 138 192
Inventory Days 137 84 84 47 45 53 27 41 68 46 93 143
Days Payable 169 129 130 133 163 154 91 106 159 105 154 244
Cash Conversion Cycle 63 34 16 22 21 56 62 69 48 45 77 92
Working Capital Days 59 42 39 43 50 79 77 90 133 73 107 213
ROCE % 20% 14% 17% 26% 29% 22% 24% 22% 20% 54% 9% 2%

Shareholding Pattern

Numbers in percentages

Mar 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
71.01% 71.07% 71.09% 71.14% 71.15% 71.15% 71.15% 70.60% 70.60% 70.60% 70.60% 70.60%
28.99% 28.93% 28.91% 28.86% 28.85% 28.86% 28.85% 29.40% 29.38% 29.41% 29.39% 29.39%
No. of Shareholders 3283232,5224,2595,2156,9396,9467,1637,3057,0556,9186,868

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Aug 2022
    Transcript
    Notes
    PPT
  • Feb 2022
    Transcript
    Notes
    PPT
  • Oct 2021
    Transcript
    Notes
    PPT
  • Sep 2021
    Transcript
    Notes
    PPT
  • Jun 2019
    Transcript
    Notes
    PPT